Cohort Study of Patients With Primary Hepatocellular Carcinoma or Cholangiocarcinoma
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Age ≥ 18 years olds
• Medical care in Nephrology department since 2015
⁃ Cholangiocarcinoma:
⁃ \- Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease
⁃ Hepatocellular carcinoma:
• Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI
• Hepatocellular histologically documented
Locations
Other Locations
France
Serviec hépatologie-Hôpital Saint Antoine
RECRUITING
Paris
Contact Information
Primary
Marie LEQUOY, MD
marie.lequoy@aphp.fr
+330149283154
Time Frame
Start Date: 2020-09-02
Estimated Completion Date: 2030-09
Participants
Target number of participants: 1250
Treatments
patients with Hepatocellular carcinoma
patients with Cholangiocarcinoma
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris